BTBD7 anticorps

N° du produit ABIN7265954

Détail du produit anti-BTBD7 anticorps

Antigène: BTBD7 (BTB (POZ) Domain Containing 7 (BTBD7))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BTBD7 est non-conjugé

Application: Western Blotting (WB)

Fonction: BTBD7 Rabbit pAb

Réactivité croisée: Humain, Souris, Rat

Attributs du produit: Polyclonal Antibodies

Purification: Affinity purification

Immunogène: Recombinant protein of human BTBD7.

Isotype: IgG

Information d'application

Indications d'application: WB,1:500 - 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur BTBD7

Antigène: BTBD7 (BTB (POZ) Domain Containing 7 (BTBD7))

Autre désignation: BTBD7 (BTBD7 Produits)

Synonymes: anticorps wu:fd08g07, anticorps si:dkeyp-55f12.1, anticorps FUP1, anticorps 5730507E09Rik, anticorps 8030448M07, anticorps E130118E17Rik, anticorps mKIAA1525, anticorps BTB (POZ) domain containing 7, anticorps BTB domain containing 7, anticorps btbd7, anticorps BTBD7, anticorps Btbd7

Sujet: Acts as a mediator of epithelial dynamics and organ branching by promoting cleft progression. Induced following accumulation of fibronectin in forming clefts, leading to local expression of the cell-scattering SNAIL2 and suppression of E-cadherin levels, thereby altering cell morphology and reducing cell-cell adhesion. This stimulates cell separation at the base of forming clefts by local, dynamic intercellular gap formation and promotes cleft progression (By similarity.,FUP1,BTBD7,Cancer,Tumor biomarkers,BTBD7

Poids moléculaire: 13kDa

ID gène: 55727

UniProt: Q9P203